Developing a tool to assess fluid status in patients with acute kidney injury
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
This study is testing a new tool to help doctors better understand fluid levels in patients with acute kidney injury to improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Hertfordshire Academic / other |
| Locations | 1 site (Stevenage) |
| Trial ID | NCT05538351 on ClinicalTrials.gov |
What this trial studies
This study focuses on developing an Enhanced Fluid Assessment Tool specifically for patients experiencing Acute Kidney Injury (AKI). It involves identifying effective methods for assessing fluid status, including bioimpedance and patient-reported symptoms. The study is divided into three workstreams: the first identifies useful assessment techniques, the second ranks these techniques to create the tool, and the third evaluates the tool's practicality in clinical settings. The goal is to standardize fluid assessment to improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients over 18 years old who are diagnosed with acute kidney injury within 72 hours of hospital admission.
Not a fit: Patients requiring dialysis, those receiving end-of-life care, or individuals with certain medical conditions like acute coronary syndrome will not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could lead to more accurate fluid management in patients with AKI, potentially reducing kidney damage and improving recovery.
How similar studies have performed: While the approach to developing a standardized fluid assessment tool is innovative, similar studies have shown the importance of accurate fluid management in AKI, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Workstream 1 and 3 (phase 3): Patients who will be included in the study will be Adult patients (over 18 years old) identified as having an acute kidney injury (AKI) within 72 hours of admission to hospital. Workstream 2: Experts in fluid assessment (Doctors, Nurses and AHPs). Persons included will be experts in their field of practice and have a recognised expertise in fluid assessment. Workstream 3: Phase 1: Experts in fluid assessment (Doctors, Nurses and AHPs). Phase 2: Staff nurses currently working on a clinical ward. Exclusion Criteria: * Patients who have kidney failure requiring dialysis or who are being conservatively managed. * Patients who are receiving end of Life (EoL) care. * Patients who have a pacemaker as this interferes with bioimpedance (WS1+3). * There is no baseline creatinine. * The patient has acquired an AKI 72 hours after admission to hospital. * The patient has acute coronary syndrome
Where this trial is running
Stevenage
- East and North Hertfordshire NHS Trust, Lister Hospital — Stevenage, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Natalie Pattison — East and North Herts
- Study coordinator: Natalie Pattison
- Email: natalie.pattison@nhs.net
- Phone: 0745322056
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.